LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U. obesity biotech Metsera marks an aggressive shift ...
A severely anorexic young woman was prescribed blockbuster weight loss jab Wegovy by one of the UK's biggest online ...
Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive shift from the Danish drugmaker as it seeks to regain ground in the weight-loss drug market ...
Are weight-loss drugs the medical innovation the insurance industry has been waiting for? Could they reshape claims experience across mortality, ...
Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong international demand for weight-loss drugs ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U. Food and Drug Administration's new ...
Lilly moved first. In January 2024, it launched LillyDirect, linking patients with telehealth providers and home delivery for its diabetes and weight-management portfolio. Pfizer followed in August ...
Americans are getting slimmer; Gallup says the obesity rate has decreased along with increased use of weight loss drugs such ...
Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...
A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...
Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...